Funding Opportunities Related To COVID-19

Last updated on May 29, 2020

The OSR, Office of Clinical Trial Activation (OCTA), and Contracts and Grants Accounting (CGA) are working to ensure continuity of services for researchers, as well as prioritizing COVID-19 research and clinical trials.

Go to our COVID-19 page for sponsor specific guidance, the impact of research and additional resources

Below are funding opportunities related to COVID-19 seperated by Sponsor. 

Please notify your RSC of any intention to submit a proposal ASAP.

 

ADA - American Diabetes Association

American Diabetes Association COVID-19 and Diabetes Research Call for Application (see RFA). Due May 22nd.

 

AHA - American Heart Association

 

AHRQ - Agency for Healthcare research and Quality

  • PA-20-070 Competitive Revision Supplements to Existing AHRQ Health Service Research (HSR) Grants and Cooperative Agreements to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19 (Supplement - Clinical Trial Optional) Due: May 29, 2020, 5 PM local time
  • PA-20-072 Competitive Revision Supplements to Existing AHRQ Patient Centered Outcomes Research (PCOR) Grants and Cooperative Agreements to Evaluate Helth System and Healthcare Professional Responsiveness to COVID-19 (Supplement - Clinical Trial Optional) Due: May 29, 2020, 5 PM local time

 TOP

BARDA - Biomedical Advanced Research and Development Authority

 TOP

C3.ai Digital Transformation Instititue

  • Mitigation of COVID-19 and Future Pandemics
    • Deadline May 1, 2020
    • Co-Investigators can be from any institution, but Principal Investigators must be researchers from C3.ai DTI consortium member institutions, including the University of California, Berkeley (UC Berkeley), C3.ai, Microsoft, the University of Illinois at Urbana-Champaign (UIUC), Carnegie Mellon University, University of Chicago, MIT, and Princeton University.  

 

 TOP

CDC - Center for Disease Control

TOP

CIRM - California Institute for Regenerative Medicine

 TOP

Emergent Ventures - Mercatus Center at George Mason University

  • Fastgrants.org 
    • No specific due date, decisions made within 48hours - first award will be made April 12th
    • Must be a currently working on a COVID-19 project

TOP

Harrington Discovery Institute

TOP

Henry Wheeler Center for Emerging & Neglected Diseases (CEND)

 

TOP

National Autonomous University of Mexico (UNAM) and University of California (UC) through Alianza UCMX)

TOP

NIH - National Institutes of Health

Go to the NIH COVID-19 Information for NIH Applicants and Recipients page for a complete list of Funding Opportunities Specific to COVID-19

 

 NCI - NOT-CA-20-065 Request For Information (RFI): Strategy for Research in Coronavirus Serology Testing and Serological Sciences, Response Due: May 26, 2020

 

NCI - NOT-CA-20-054 Contributing to the Global COVID-19 Crisis Response by Allowing Some NCI-supported Projects to be redirected to COVID-19-Related Research During the Crisis

 

NHLBI - Research Opportunity Announcement (ROA) OTA-20-011 ACTIV Integration of Host-targeting Therapies for COVID19 Stage 1 Letters of Request Due: Friday, May 15, 5 PM EDT. Additional letters of request considered on a monthly basis June 15, July 15, and August 15.

 

NIBIBNIH POCTRN - Fast-Track Program for COVID-19 Test Development and Distribution Innovative Technologies to Increase U.S. Capacity for COVID-19 Testing Rolling Submission from April 29, 2020 until further ntoice.

 

Below is a listing of Notices of Special Interest (NOSIs) for:

 

COVID-19 Applications:

NIH IC NOSI NOSI Expiration Title FOAs Used
NIAID      
  • PAR-20-177 Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed) Due: Rolling Basis from April 30, 2020 -  April 29, 2021
  • PAR-20-178 Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Included) Due: Rolling Basis from April 30, 2020 - April 29, 2021
NIH Office of Strategic Coordination      
  • RFA-RM-20-020 NIH Director's Emergency Tranformative Research Awards (R01 Clinical Trial Optional Due: September 30, 2020
  • RFA-RM-20-021 NIH Director's Emergency Early Independence Awards (DP5 Clinical Trial Optional) Due: September 4, 2020 
NIAID NOT-AI-20-051 9/8/21 Select Research Areas for Severe Acute-Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
  • PA-20-200 NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed) Standard Due Dates apply, first Standard Due Date is June 16, 2020. Standard AIDS Dates apply, first Standard AIDS Date is September 7, 2020 
  • PA-19-272 PHS 2019-02 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent  SBIR R43/R44 Clinical Trial Not Allowed) Standard Due Dates apply (AIDS Due Date - not applicable)
  • PA-19-270 PHS 2019-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR R41/R42 Clinical Trial Not Allowed) Standard Due Dates apply (AIDS Due Date - not applicable)
OPPNET, NIA, NIAAA, NICHD, NIDA, NIMH, NINDS, NINR, NIMHD, NCCIH, OBSSR NOT-OD-20-103 3/18/21 Notice of Additional Due Date and Additional "Areas of Focus Especially of Interest" of PAR-19-373 and PAR-19-384
  • PAR-19-373 Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01-Clinical Trials Not Allowed) Due: 6/8/20, 3/17/21
  • PAR-19-384 Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01-Basic Experimental Studies with Humans Required) Due: 6/8/20, 3/17/21
NIDCR

NOT-DE-20-023

FAQs

  Infrastructure Access for Research on Coronavirus disease 2019 (COVID-19) Conducted in the National Dental Practice-based Research Network
  • PAR-20-073 National Dental Practice-based Research Network Infrastructure Access (X01 Clinical Trial Not Allowed) Due: 6/1/20, 9/1/20, 11/2/20, 9/1/21, 9/1/22
NLM NOT-LM-20-011 6/17/20 Data Driven Research on Coronavirus Disease 2019 (COVID-19)
  • PAR-19-053 NIH Exploratory/Developmental research grant Program (Parent R21 Clinical trial Not Allowed) Due: 6/16/20
NCATS NOT-TR-20-012 10/17/20 Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)
  • PAR-17-465 Bench Testing Therapeutic/Indication Pairing Strategies (UG3/UH3) Due: 6/26/20
  • PA-18-462 Clinical Trial Planning Therapeutic/Indication Pairing Strategies (U34 Clinical Trial Not Allowed) Due: 6/16/20, 10/26/20
  • PAR-18-332 Clinic Testing Therapeutic/Indications Pairing Strategies (U01 Clinical Trial Required) Due: 6/5/20, 10/5/20
NIBIB

NOT-EB-20-007

 3/31/21 Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)
  • PA-19-056 NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) Due: 6/5/20
  • PA-18-418 NIBIB Research Project Grant (R01 Clinical Trial Required) Due: 6/5/20
  • PAR-18-530 Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01-Clinical Trial Optional) Due: 6/5/20
  • PAR-20-155 Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) Due: 6/5/20
  • PAR-20-084 NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional) Due: 6/16/20
  • PAR-18-433 NIBIB Exploratory/Development Research Grant Program (R21 Clinical Trial Optional) Due: 6/16/20
  • PA-19-052 NIH Small Research Grant Program (R03 Clinical Trial Not Allowed) Due: 6/16/20
NIEHS

NOT-ES-20-015

 Rescinded 4/10/20

replaced by NOT-ES-20-20

4/9/20 NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19)
  • RFA-ES-19-011 Mechanism for Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed) Due: see RFA
NIEHS

NOT-ES-20-020

5/4/21 NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19)
  • RFA-ES-19-011 Mechanism for Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed) Due: see RFA - if applying for a NEW R21 that does not build off of an existing NIEHS grant.

 

  TOP

COVID-19 Supplements for Exisiting Awards:

NIH IC COVID NOSI

Competing

PA-20-135 expands scope

Competing 

PA-18-935 

expands scope

Adminis. 

 PA-18-591

within scope

Noted Requirements (please see NOSI for all requirements specified) Deadline Release Expires
NIAID NOT-AI-20-034 X     FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will expire June 25  Rolling basis from 3/25/20-3/25/21  3/25/20  3/25/21
NIAID

NOT-AI-20-031

Rescinded 5/19/20

Replaced by NOSI NOT-AI-20-051 R03, R41/R42, R43/R44 

or use

PAR-177 PAR-178

See Application Grid above

    X

Admin. Supplement cannot use streamline submission in eRA Commons

FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will expire June 25

 Rolling basis from 4/5/20-4/5/21  3/27/20

 4/5/21

5/19/20

NIBIB NOT-EB-20-008 X   X

Limited to DP1, DP2, P41, R00, R01, R03, R15, R21, R24, R37, R41, R43, R44, R56, U01, U18, U24, U2C, U54, UG3, UH2, UH3

Admin. Supplement cannot use streamline submission in eRA Commons

FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will expire June 25

Rolling basis from 4/2/20-11/10/20 4/10/20 11/10/20
NIEHS

NOT-ES-20-014

Rescinded 4/10/20

replaced by NOT-ES-20-017

X    

 Must have active grant from:

  • RFA-ES-19-003 Worker Training U45
  • RFA-ES-19-004  HAZNAT Train UH4
  • RFA-ES-15-018 Worker Train UH4
  • RFA-ES-19-009 SBIR
 4/24/20  3/27/20

 4/25/20

4/10/20

NIEHS

NOT-ES-20-015

Rescinded 4/10/20

replaced by NOT-ES-20-20

X    

One year support for supplements. FOA will be reissued with FORMS-F on May 25. FORMS-E will expire June 25

New R21 applications use RFA-ES-19-011 (see table above) up to two years support.

 

5/1/ earliest see NOSI 4/9/20

5/4/21

4/10/20

NIEHS NOT-ES-20-017 X    

Must have active grant from

RFA-ES-14-008, RFA-ES-14-009, RFA-ES-15-018, RFA-ES-17-004, RFA-ES-18-006, RFA-ES-19-009

4/24/20 4/10/20 4/25/20
NIEHS NOT-ES-20-20   X X

FOA will be reissued with FORMS-F on May 25. FORMS-E will expire June 25.

New R21 applications use RFA-ES-19-011 (see table above)

Earliest 5/1/20, see NOSI for furture dates 4/10/20 5/4/21

OSC

Common Fund

NOT-RM-20-015 X    

Pre-application teleconference to be posted on Common Fund site.

Limited to D43, DP2, DP5, DP7, R01, R24, R25, R35, U01, U18, U19, U24, U2C, U2R, U42, U54, UG3, UH2, UH3, UM1

FOA will be reissued with FORMS-F on May 25. FORMS-E and F will expire  on June 20.

Rolling Basis from 4/15/20-6/19/20 4/27/20 6/20/20
NCATS NOT-TR-20-017 X    

Only existing UG3/UH3, R43/R44, R41/R42, R01, U01 NCATS/NIH Microphysiological Systems

FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will expire June 25

Rolling basis from 5/15/20-1/25/22 4/9/20 1/26/22
NCATS NOT-TR-20-028 X   X

Soliciting current CTSA UL1 & U24 recipients of

RFA-TR-17-006 RFA-tr-15-004 PAR-18-940 UL1 component only                PAR-18-464 UL1 component only                 PAR-15-304 UL1 component only                 RFA-TR-14-009 UL1 Component only                 

Admin. Supp. Cannot use streamline submission in eRA.

FOA will be reissued with FORMS-F on May 25. FORMS-E FOA expires June 25

Rolling basis from 5/4/20-11/11/20 4/23/20 11/11/20
NIAAA NOT-AA-20-011   X X

Admin. Supp. Cannot use streamline submission in eRA.

FOA will be reissued with FORMS-F on May 25. FORMS-E FOA expires June 25

Rolling basis 5/15/20-4/16/21 4/16/20 4/16/21
NIA/NIMH

NOT-AG-20-022

FAQs

  X X

Admin. Supp. Cannot use streamline submission in eRA.

FOA will be reissued with FORMS-F on May 25. FORMS-E FOA expires June 25

Rolling basis from 4/6/20-5/1/21 4/2/20 5/21/21

NCCIH/ORWH

NOT-AT-20-012   X X

Only existing awardees of NCCIH active awards.

Admin. Supp. Cannot use streamline submission in eRA.

PA-18-591 and PA-18-935 were reissued with FORMS-F on 5/25/20

Applications started using FORMS-E must be completed by 6/25/20

Rolling through 8/17/20 5/26/20 8/18/20

NCCIH/NIA/

NIAAA

NOT-AT-20-011   X X

Admin. Supplement cannot use streamline submission in eRA Commons

FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will be accepted through 6/25/20

Rolling basis from 4/10/20-10/6/20 4/10/20 10/7/20
NCI NOT-CA-20-042   X X

Admin. Supplement cannot use streamline submission in eRA Commons

FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will be accepted through 6/25/20

Contact parent Program Director before writing and submitting applications.

Rolling basis from 4/14/20-6/25/20 4/10/20 6/26/20
NIDA NOT-DA-20-047   x x

Admin. Supplement cannot use streamline submission in eRA Commons

FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will be accepted through 6/25/20

Rolling basis from 3/19/20-3/31//21 3/19/20 3/31/21
NIDCD NOT-DC-20-004   X X

Admin. Supplement cannot use streamline submission in eRA Commons

FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will be accepted through 6/1/20

Rolling basis from 4/7/20-6/1/20 4/9/20 6/2/20
NIDCR

NOT-DE-20-022

FAQs

  X X

Includes R42, R44, SB1, K01, K08, K23, K25, K99/R00, R01, R15, R37, U01, U19, UH3

Admin. Supplement cannot use streamline submission in eRA Commons

Must use application form package with the Competition ID that contains FORMS-F-ADMINSUPP

6120 and 11/2/20 5/5/20  
NIDDK NOT-DK-20-018   X  

FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will be accepted through 6/1/20

Contact with NIDDK program staff is strongly recommended

6/1/20 4/9/20 6/2/20
NIDDK NOT-DK-20-020   X  

FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will be accepted through 6/1/20

Contact with NIDDK program staff is strongly recommended

6/1/20 4/9/20 6/2/20
NIGMS NOT-GM-20-025   X    

FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will expire June 25

 Rolling basis from 3/25-2/5/21  3/25/20  2/6/21
NIGMS NOT-GM-20-027   X   Notify contact on NOSI when application submitted. 5/5/20 4/10/20 5/6/20
NIGMS NOT-GM-20-033   X  

For awardees with an active NIGMS IDeA-CTR U54

Must use application form package with Competition ID NOT-GM-20-033-FORMS-F

6/18/20 5/15/20 6/19/20
NHGRI

NOT-HG-20-030

  X X

Admin. Supp. cannot use streamline submission in eRA Commons.  Contact with NHGRI Program staff strongly recommended

 Rolling basis from 4/1-5/15  3/31/20  5/16/20
                 
NHLBI

NOT-HL-20-782

X    

Phase I-III CT, parent P01, R01, R33, R41, R42, R43, R44, U01, U24, U54, UH3, UM1

OA will be reissued with FORMS-F on May 25. FORMS-E FOA expires June 25

Rolling basis from 5/1/20-10/5/20 4/27/20 10/6/20
NHLBI

NOT-HL-20-757

FAQs

Expires 5/15/20

see

NOT-HL-20-782

or

OTA-20-011

  X X

Admin. Supp. Cannot use streamline submission in eRA.

FOA will be reissued with FORMS-F on May 25. FORMS-E FOA expires June 25

Contact with NHLBI progran staff well in advance is strongly recommended.

 Rolling basis from 3/17-05/15/20  3/17/20  5/15/20

NLM

NOT-LM-20-010     X

Admin. Supplement cannot use streamline submission in eRA Commons

FOA will be reissued with FORMS-F on May 25. FORMS-E expires June 25

6/1/20 4/16/20 6/2/20

NIMHD

NIA/NIMH

NOT-MD-20-019   X X

FOA will be reissued with FORMS-F on May 25. FORMS-E FOA expires June 25

Rolling basis from 5/1/20-5/1/21 4/9/20 5/1/21

NIMH

NIA/NIAAA/

NIMHD/

ODP

NOT-MH-20-047   X X

May be co-funded by ODP

FOA will be reissued with FORMS-F on May 25. FORMS-E FOA expires June 25

Rolling basis from 3/27/20-4/15/21 4/9/20 4/16/21

NINDS

NOT-NS-20-046   X X

Active U01 or U24 for FOA RFA-NS-19-024, RFA-NS-17-02, RFA-NS-16-015, RFA-NS-13-016, RFA-NS-11-010

Admin. Supplement cannot use streamline submission in eRA Commons

FOA will be reissued with FORMS-F on May 25. FORMS-E expires June 25

Rolling basis from 4/6/20-5/8/20 4/14/20 5/9/20

NINDS

NOT-NS-20-051

NOT-NS-20-074 adds RF1 to eligible mechanisms

  X X

Limited to P01, P50, RF1,R00, R01, R03, R15, R33, R35, R41, R42, R43, R44, R61, U01, U19, U24, U44, U54, UG3, UH3

Admin. Supplement cannot use streamline submission in eRA Commons

FOA will be reissued with FORMS-F on May 25. FORMS-E expires June 25

Rolling basis from 4/15/20-4/14/21 4/30/20 4/15/21

OD

Office of the Director

 

NOT-OD-20-107     X

EsixtingECHO Cohorts, Coordinating Center, Data Analysis Center and PRO Core Awardees

Existing Subawardees not eligible

Use application form package with Competition ID that contains FORMS-F-ADMINSUPP

6/22/20 5/27/20 6/23/20

OBSSR/NHLBI/

NIA/NIAAA/

NIDDK/NIEHS/

NCCIH/NCI

NOT-OD-20-097   X X

Admin. Supplement cannot use streamline submission in eRA Commons

FOA will be reissued with FORMS-F on May 25. FORMS-E expires June 25

Rolling basis from 4/13/20-3/31/21 4/13/20 4/1/21

NCATS

NOT-TR-20-011     X

Supplements U01-PAR-19-099 R21-PAR-19-100 UL1-PAR-19-337

Admin. Supp. cannot use streamline submission in eRA Commons.

FOA will be reissued with FORMS-F on May 25. FORMS-E expires June 25

5/4/20 AND 11/2/20 3/24/20 7/10/21

NCATS

NOT-TR-20-016     X

Admin. Supp. cannot use streamline submission in eRA Commons.

FOA will be reissued with FORMS-F on May 25. FORMS-E expires June 25

Rolling basis from 5/15/20-1/25/22 4/9/20 1/26/22

NIAID

NOT-AI-20-040      

Early termination of NOT-AI-20-030 (expires 4/8/20). Please use NOT-AI-20-034 and NOT-GM-20-025 (listed above)

    4/8/20

 TOP

NSF - National Science Foundation

 

 TOP

PCORI

Complete list of funding opportunities

 

 

 TOP

UC - RGPO  University of California, Research Grants Program Office

TOP

UCSF 

 TOP

US Army Medical Research & Development Commands's CDMRP

FY20 Peer Review Medical Research Program Funding Opportunities focused on COVID-19 and SARS-CoV-2 in two topic areas, "emerging viral diseases" and "respiratory health."

White House

  TOP